共 50 条
- [21] Comparative hospitalization risk for SARS-CoV-2 Omicron and Delta variant infections, by variant predominance periods and patient-level sequencing results, New York City, August 2021-January 2022INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (01)Greene, Sharon K.Levin-Rector, AlisonKyaw, Nang T. T.Luoma, ElizabethAmin, HellyMcGibbon, EmilyMathes, Robert W.Ahuja, Shama D.
- [22] Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022EUROSURVEILLANCE, 2022, 27 (10)Fonager, JannikBennedbaek, MarcBager, PeterWohlfahrt, JanEllegaard, Kirsten MarenIngham, Anna CaciliaEdslev, Sofie MarieStegger, MarcSieber, Raphael NiklausLassauniere, RiaFomsgaard, AndersLillebaek, TroelsSvarrer, Christina WiidMoller, Frederik TrierMoller, Camilla HoltenLegarth, RebeccaSydenham, Thomas VognbjergSteinke, KatPaulsen, Sarah JuelCastruita, Jose Alfredo SamaniegoSchneider, Uffe VestSchouw, Christian HojteNielsen, Xiaohui ChenOvervad, MariaNielsen, Rikke ThoftMarvig, Rasmus L.Pedersen, Martin SchouNielsen, LeneNilsson, Line LyngeBybjerg-Grauholm, JonasTarpgaard, Irene HarderEbsen, Tine SnejbjergLam, Janni Uyen HoaGunalan, VithiagaranRasmussen, Morten
- [23] Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5-and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults-Increasing Community Access to Testing Program, United States, December 2022-January 2023MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (05): : 119 - 124Link-Gelles, RuthCiesla, Allison AvrichRoper, Lauren E.Scobie, Heather M.Ali, Akilah R.Miller, Joseph D.Wiegand, Ryan E.Accorsi, Emma K.Verani, Jennifer R.Shang, NongDerado, GordanaBritton, AmadeaSmith, Zachary R.Fleming-Dutra, Katherine E.
- [24] Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residentsGEROSCIENCE, 2024,Abul, YasinNugent, ClareVishnepolskiy, IgorWallace, TiffanyDickerson, EvanHolland, LaurelEsparza, IvaWinkis, MandiWali, Kazi TanveeChan, Philip A.Baier, Rosa R.Recker, AmyKaczynski, MatthewKamojjala, ShreyaPralea, AlexanderRice, HaileeOsias, OlubunmiOyebanji, Oladayo A.Olagunju, OlajideCao, YiLi, Chia JungRoederer, AlexPfeifer, Walther M.Bosch, JuergenKing, Christopher L.Nanda, AmanMcNicoll, LynnMujahid, NadiaRaza, SakeenaTyagi, RohitWilson, Brigid M.White, Elizabeth M.Canaday, David H.Gravenstein, StefanBalazs, Alejandro B.
- [25] Investigation of SARS-CoV-2 Transmission Associated With a Large Indoor Convention - New York City, November-December 2021MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (07): : 243 - 248Sami, SamiraHorter, LibbyValencia, DianaThomas, IsabelPomeroy, MaryWalker, BriannaSmith-Jeffcoat, Sarah E.Tate, Jacqueline E.Kirking, Hannah L.Kyaw, Nang Thu ThuBurns, RebeccaBlaney, KathleenDorabawila, VajeeraHoen, RebeccaZirnhelt, ZacharySchardin, CodyUehara, AnnaRetchless, Adam C.Brown, Vance R.Gebru, YonathanPowell, CharlesBart, Stephen M.Vostok, JohannaLund, HannahKaess, JessicaGumke, MeganPropper, RandyThomas, DeepamOjo, MojisolaGreen, AlisonWieck, MorganWilson, EricaHollingshead, Ryan J.Nunez, Sheila, VSaady, Dawn M.Porse, Charsey ColeGardner, KyleDrociuk, DanielScott, JuliaPerez, TaidyCollins, JimShaffner, JuliePray, IanRust, Laura T.Brady, ShaneKerins, Janna L.Teran, Richard A.Hughes, VictoriaSepcic, VictoriaLow, Eleanor W.
- [26] Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023Scientific Reports, 14Jiratchaya PuenpaJira ChansaenrojKamol SuwannakarnYong Poovorawan
- [27] Variant-specific introduction and dispersal dynamics of SARS-CoV-2 in New York City-from Alpha to OmicronPLOS PATHOGENS, 2023, 19 (04)Dellicour, Simon W.Hong, Samuel. L.Hill, VerityDimartino, DaciaMarier, ChristianZappile, PaulHarkins, Gordon. W.Lemey, PhilippeBaele, GuyDuerr, RalfHeguy, Adriana
- [28] Assessment of clinical characteristics and mortality in patients hospitalized with SARS-CoV-2 from January 2022 to November 2022, when Omicron variants were predominant in the United StatesCURRENT MEDICAL RESEARCH AND OPINION, 2025, 41 (01) : 71 - 82Scott, AmiePuzniak, LauraMurphy, Michael V.Benjumea, DarrinRava, AndrewBenigno, MichaelAllen, Kristen E.Stanford, Richard H.Manuel, FadiChambers, RichardReimbaeva, MayaAnsari, WajeehaCha-Silva, Ashley S.Draica, Florin
- [29] Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York CityBreast Cancer Research and Treatment, 2020, 182 : 239 - 242Kevin KalinskyMelissa K. AccordinoKristina HosiJessica E. HawleyMeghna S. TrivediKatherine D. CrewDawn L. Hershman
- [30] Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York CityBREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 239 - 242Kalinsky, KevinAccordino, Melissa K.Hosi, KristinaHawley, Jessica E.Trivedi, Meghna S.Crew, Katherine D.Hershman, Dawn L.